Trump and tariffs
United States President Donald Trump’s tariff buffers can impact a number of sectors of export from India to the U.S.
While it is too early to estimate the ‘plus and minus’ of specific sectors, our pharma exports are better placed. As we import 70% of our active pharmaceutical ingredients, any adverse pressure by the U.S. on China reduces our API prices from China. It could enable us to increase our market share of pharma products to the U.S., even at some premium.
R. Narayanan,
Navi Mumbai
When China has trade relations with many countries beyond American shores, and is edging past the U.S. as a dominant global player in crucial areas including AI, Mr. Trump needs to treat China on an even keel and consider it as a trading partner to improve bilateral ties. In a multipolar world, America’s notion that it alone can control others by tariffs, sanctions and threats is unlikely to succeed. The sooner this realisation dawns on Mr. Trump, the better it would be for the U.S.
Prabhu Raj R.,
Bengaluru
Crises and India
The global interconnectedness of economies has brought benefits of scale, but with the wave of deglobalisation and ‘forever crises’ that plague the world, one wonders whether such connectivity is not all it’s cracked up to be. If other nations are putting themselves ‘first’, by virtue of which they disregard the rules-based order that built our global society, perhaps it is time India went its way.
Anany Mishra,
Bhilai, Chhattisgarh
Published - February 05, 2025 12:24 am IST
